AAAAAA
Results:
1-10
|
Results: 10
Authors:
SCHLIENGER RG
KNOWLES SR
SHEAR NH
Citation: Rg. Schlienger et al., LAMOTRIGINE-ASSOCIATED ANTICONVULSANT HYPERSENSITIVITY SYNDROME, Neurology, 51(4), 1998, pp. 1172-1175
Authors:
SCHLIENGER RG
SHEAR NH
Citation: Rg. Schlienger et Nh. Shear, ANTIEPILEPTIC DRUG HYPERSENSITIVITY SYNDROME, Epilepsia, 39, 1998, pp. 3-7
Authors:
SCHLIENGER RG
SHAPIRO LE
SHEAR NH
Citation: Rg. Schlienger et al., LAMOTRIGINE-INDUCED SEVERE CUTANEOUS ADVERSE REACTIONS, Epilepsia, 39, 1998, pp. 22-26
Authors:
SCHLIENGER RG
OH PI
KNOWLES SR
SHEAR NH
Citation: Rg. Schlienger et al., QUANTIFYING THE COSTS OF SERIOUS ADVERSE DRUG-REACTIONS TO ANTIEPILEPTIC DRUGS, Epilepsia, 39, 1998, pp. 27-32
Authors:
SCHLIENGER RG
SHEAR NH
Citation: Rg. Schlienger et Nh. Shear, DIDMOHS - A PROPOSED CONSENSUS NOMENCLATURE FOR THE DRUG-INDUCED DELAYED MULTIORGAN HYPERSENSITIVITY SYNDROME - IN REPLY, Archives of dermatology, 134(7), 1998, pp. 876-876
Authors:
SCHLIENGER RG
SHEAR NH
Citation: Rg. Schlienger et Nh. Shear, SEROTONIN SYNDROME, Deutsche Medizinische Wochenschrift, 122(48), 1997, pp. 1495-1499
Authors:
SCHILLER PI
MESSMER SL
HAEFELI WE
SCHLIENGER RG
BIRCHER AJ
Citation: Pi. Schiller et al., ANGIOTENSIN-CONVERTING ENZYME INHIBITOR-INDUCED ANGIOEDEMA - LATE-ONSET, IRREGULAR COURSE, AND POTENTIAL ROLE OF TRIGGERS, Allergy, 52(4), 1997, pp. 432-435
Authors:
SCHLIENGER RG
KNOWLES SR
SHEAR NH
Citation: Rg. Schlienger et al., THE ECONOMIC-IMPACT OF SERIOUS ADVERSE DRUG-REACTIONS (ADRS) TO ANTICONVULSANTS, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 3-3
Authors:
SCHLIENGER RG
FLUSCHER TF
HAEFELI WE
Citation: Rg. Schlienger et al., CLINICAL PHARMACISTS EFFECT ON DRUG INFORMATION REQUESTS, The Annals of pharmacotherapy, 30(1), 1996, pp. 86-87
Authors:
SCHLIENGER RG
SAXER M
HAEFELI WE
Citation: Rg. Schlienger et al., REVERSIBLE AGEUSIA ASSOCIATED WITH LOSARTAN, Lancet, 347(8999), 1996, pp. 471-472
Risultati:
1-10
|